Top ▲

CD molecules C

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Overview

Click here for help

« Hide

Cluster of differentiation refers to an attempt to catalogue systematically a series of over 300 cell-surface proteins associated with immunotyping. Many members of the group have identified functions as enzymes (for example, see CD73 ecto-5'-nucleotidase) or receptors (for example, see CD41 integrin, alpha 2b subunit). Many CDs are targeted for therapeutic gain using antibodies for the treatment of proliferative disorders. A full listing of all the Clusters of Differentiation proteins is not possible in the Guide to PHARMACOLOGY; listed herein are selected members of the family targeted for therapeutic gain.

Targets

3362
Click here for help

CD1d molecule Show summary » More detailed page go icon to follow link

CD2 C Show summary » More detailed page go icon to follow link

CD3e C Show summary » More detailed page go icon to follow link

CD4 Show summary » More detailed page go icon to follow link

CD6 C Show summary » More detailed page go icon to follow link

CD14 molecule Show summary » More detailed page go icon to follow link

FcγRIIIa (Fc gamma receptor IIIa / CD16A) Show summary » More detailed page go icon to follow link

CD19 Show summary » More detailed page go icon to follow link

CD20 (membrane-spanning 4-domains, subfamily A, member 1) C Show summary » More detailed page go icon to follow link

SIGLEC2 (CD22) C Show summary » More detailed page go icon to follow link

CD24 molecule Show summary » More detailed page go icon to follow link

CD28 Show summary » More detailed page go icon to follow link

SIGLEC3 (CD33) C Show summary » More detailed page go icon to follow link

CD36 molecule (CD36 blood group) Show summary » More detailed page go icon to follow link

CD37 (CD37 molecule) Show summary » More detailed page go icon to follow link

CD38 Show summary » More detailed page go icon to follow link

CD47 Show summary » More detailed page go icon to follow link

CD52 C Show summary » More detailed page go icon to follow link

CD55 molecule (Cromer blood group) Show summary »

NCAM1 (neural cell adhesion molecule 1 (CD56)) Show summary » More detailed page go icon to follow link

selectin P (CD62) Show summary » More detailed page go icon to follow link

selectin E (CD62E) Show summary »

CD66e (CEACAM5) Show summary » More detailed page go icon to follow link

transferrin receptor (CD71) Show summary »

CD74 Show summary » More detailed page go icon to follow link

CD79B Show summary » More detailed page go icon to follow link

CD80 C Show summary » More detailed page go icon to follow link

LILRA4 (leukocyte immunoglobulin like receptor A4 / CD85g) Show summary » More detailed page go icon to follow link

LILRB1 (leukocyte immunoglobulin like receptor B1 / CD85j) Show summary » More detailed page go icon to follow link

LILRB4 (leukocyte immunoglobulin like receptor B4 / CD85k) Show summary »


Target Id 3362
Nomenclature leukocyte immunoglobulin like receptor B4
Systematic nomenclature CD85k
Common abbreviation LILRB4
Previous and unofficial names HM18 | ILT3 | leucocyte Ig-like receptor B4 | LIR-5
Genes LILRB4 (Hs), Lilrb4 (Rn)
Ensembl ID ENSG00000186818 (Hs), ENSRNOG00000027811 (Rn)
UniProtKB AC Q8NHJ6 (Hs)
Inhibitors
GL-4512 (Binding) pKd 7.4 [3]
APX1 (Binding) pKd 6.5 [2], 6.4 [2]
Antibodies
rolistobart (Binding) pKd 9.1 [39]
Comment LILRB4 is an immunosuppressive immune checkpoint receptor that is expressed by leukocytes. It is important for the immune response and the development of immune tolerance. Several endogenous ligands have been reported, including fibronectin 1 [51], apolipoprotein APOE [16], secretogranin 2 [63], and activated leukocyte cell adhesion molecule (ALCAM; CD166) [62]. The LILRB4 checkpoint is implicated in tumour immune evasion [49,59,64], and for this reason it is considered as a potential oncology therapeutic target [32,60]. Small molecules and antibodies have been developed to explore pharmacological modulation of LILRB4 function [1-3,22-23]. At least two lead anti-LILRB4 monoclonals have progressed to clinical trial, IO-202 (Immune-Onc Therapeutics) [5] and MK-0482 (Merck) [39] (July 2026).

CD86 C Show summary » More detailed page go icon to follow link

FcαRI (Fc alpha receptor / CD89) Show summary » More detailed page go icon to follow link

semaphorin 4D (CD100) Show summary » More detailed page go icon to follow link

endoglin (CD105) Show summary » More detailed page go icon to follow link

basigin (Ok blood group) / CD147 Show summary » More detailed page go icon to follow link

CTLA-4 (cytotoxic T-lymphocyte-associated protein 4 (CD152)) C Show summary » More detailed page go icon to follow link

KIR3DL2 (CD158K) Show summary » More detailed page go icon to follow link

NKG2A (killer cell lectin like receptor C1 (CD159a) / CD159a) Show summary » More detailed page go icon to follow link

KLRC2 (killer cell lectin like receptor C2 (CD159c) / CD159c) Show summary »

killer cell lectin like receptor B1 (CD161) / CD161 Show summary »

SIRPA (CD172a) Show summary » More detailed page go icon to follow link

LAG3 (CD223) / CD223 Show summary » More detailed page go icon to follow link

CD226 molecule Show summary »

T-cell surface glycoprotein CD3 zeta chain (CD247) Show summary » More detailed page go icon to follow link

B7-H3 (CD276) Show summary » More detailed page go icon to follow link

ICOS (CD278) Show summary » More detailed page go icon to follow link

PD-1 (programmed cell death 1 (CD279)) C Show summary » More detailed page go icon to follow link

CD300a C Show summary » More detailed page go icon to follow link

LAIR1 (leukocyte associated immunoglobulin like receptor 1 (CD305)) Show summary » More detailed page go icon to follow link

CS1 (CD319) Show summary » More detailed page go icon to follow link

NKp30 (Natural cytotoxicity triggering receptor 3 (CD337)) Show summary » More detailed page go icon to follow link

TIM3 (CD366) Show summary » More detailed page go icon to follow link

Comments

Click here for help

Show »

Further reading

Click here for help

Show »

References

Click here for help

Show »

How to cite this family page

Database page citation:

CD molecules. Accessed on 17/11/2026. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=852.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Gibb AJ, Kelly E, Mathie AA, Peach CJ, Veale EL, Cidlowski JA, Davenport AP, Fabbro D, Spedding M, Striessnig J, Armstrong JF, Buneman OP, Faccenda E, Harding SD, Southan C, Davies JA et al. (2025) The Concise Guide to PHARMACOLOGY 2025/26: Introduction and Other Protein Targets. Br J Pharmacol. 182: S1-S23.